잠시만 기다려 주세요. 로딩중입니다.
KMID : 0964020130130020178
Journal of the Korean Liver Cancer Study Group
2013 Volume.13 No. 2 p.178 ~ p.184
A Case of Hypovascular Hepatocellular Carcinoma Invading Bile Duct with Partial Remission with Combination Therapy of Transarterial Chemoembolization and Stereotactic Body Radiation Therapy and Sorafenib
Hwang Sang-Youn

Lee Seon-Mi
Im Jung-Woo
Kim Joon-Suk
Ahn Sang-Bu
Ji Eun-Kyeong
Choi Chul-Won
Yang Kwang-Mo
Abstract
Hepatocellular carcinoma (HCC) patients with bile duct invasion have a poor prognosis because many do not receive effective treatment. Surgical resection is thought to be only option of curative treatment, increasing chance of survival, but it is possible to minor group of patients because of poor reserved liver function associated with underlying liver disease and obstructive jaundice. Therefore many clinicians or centers still select locoregional therapy such as transarterial chemoembolization (TACE), radiation therapy (RT) etc. Stereotactic body radiation therapy (SBRT) is new technology providing very highly conformal ablative radiation dose for a small numbers (1-5 fractions) of large fraction size and is expected to salvage modality for HCC showed incomplete response of TACE due to vascularity or accessibility of feeding artery. Based on above suggestions, we herein offer our experience of a patient with partial remission of tumor by combination therapy of TACE, SBRT and sorafenib. Further study, maybe regarding a combination of locoregional and systemic therapy (so called multidisciplinary approach), is necessary on how to manage HCC patients with bile duct invasion or sparse vascularity.
KEYWORD
Hypovascular hepatocellular carcinoma, Bile duct invasion, Trasnarterial chemoembolization, Stereotactic body radiation therapy
FullTexts / Linksout information
Listed journal information